What this means
This is a trial that is recruiting, and no results have been posted yet. It plans to check older adults' eyesight in local communities and provide glasses or other correction.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–100 · Older adults aged 65 and above in Shanghai, China; 154,000 people named as the target group
- Where
- 1 site
The science
- Registered title
- Shanghai Eye Study for Adults
- Trial ID
- NCT03455478 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging
- What is tested
- spectacles
- Sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Ages
- 18 Years to 100 Years
- Dates
- First posted Mar 6, 2018 · updated May 24, 2022
Registry summary
Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.
Sites (1)
- Shanghai Eye Disease Prevention & Treatment Center, Shanghai, Shanghai Municipality, China